Clinical Research Directory
Browse clinical research sites, groups, and studies.
DynamX Bioadaptor Global Post-Market Registry: Clinical Trial of the Elixir Medical DynamX Coronary Bioadaptor System
Sponsor: Elixir Medical Corporation
Summary
The goal of this registry is to confirm the safety, and performance of the DynamX Coronary Bioadaptor System in patients with coronary artery disease.
Official title: DynamX Bioadaptor Global Post-Market Registry: Clinical Trial of the Elixir Medical DynamX Coronary Bioadaptor System (Bio-RESTORE)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
5000
Start Date
2024-03-10
Completion Date
2028-12
Last Updated
2025-08-28
Healthy Volunteers
No
Conditions
Interventions
DynamX Novolimus-eluting Coronary Bioadaptor System
All patients will receive at least one DynamX Bioadaptor implant in a commercial setting in accordance with the product's Instructions for Use
Locations (17)
University Hospital St. Pölten
Pölten, Austria
Curaçao Medical Center
Willemstad, Curacao
Heartology Cardiovascular Hospital
Jakarta, Indonesia
Jakarta Heart Center
Jakarta, Indonesia
Medistra Hospital
Jakarta, Indonesia
Siloam Hospitals
Jakarta, Indonesia
Centro Cardiologico Monzino
Milan, Italy
Azienda Ospedaliera Universitaria "Federico II"
Naples, Italy
Policlinico Tor Vergata
Rome, Italy
Jordon Hospital
Amman, Jordan
The Specialty Hospital
Amman, Jordan
King Fahad Armed Forces Hospital
Jeddah, Saudi Arabia
Istanbul Medipol Mega University Hospital
Istanbul, Turkey (Türkiye)
Memorial Bahçelievler Hospital
Istanbul, Turkey (Türkiye)
Al Qassimi Hospital
Sharjah city, United Arab Emirates
Tam Duc Heart Hospital
Ho Chi Minh City, Vietnam
Kiến Giang General Hospital
Kiến Giang, Vietnam